Cwm LLC Takes $55,000 Position in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)
Cwm LLC Takes $55,000 Position in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)
Cwm LLC purchased a new stake in shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 1,800 shares of the company's stock, valued at approximately $55,000. Cwm LLC owned 0.05% of ALPS Medical Breakthroughs ETF as of its most recent filing with the SEC.
據Cwm LLC在其最近向美國證券交易委員會披露的資訊中稱，該公司在第四季度購買了阿爾卑斯山醫療突破ETF(NYSEARCA：SBIO-GET Rating)的新股。該基金購買了1,800股該公司股票，價值約55,000美元。截至最近提交給美國證券交易委員會的檔案，Cwm LLC持有阿爾卑斯山醫療突破ETF 0.05%的股份。
Several other institutional investors have also recently made changes to their positions in SBIO. Captrust Financial Advisors raised its position in shares of ALPS Medical Breakthroughs ETF by 903.6% during the 1st quarter. Captrust Financial Advisors now owns 1,666 shares of the company's stock valued at $56,000 after buying an additional 1,500 shares during the period. International Assets Investment Management LLC purchased a new stake in ALPS Medical Breakthroughs ETF in the fourth quarter valued at approximately $202,000. Jane Street Group LLC purchased a new stake in ALPS Medical Breakthroughs ETF in the first quarter valued at approximately $208,000. Citadel Advisors LLC purchased a new stake in ALPS Medical Breakthroughs ETF in the third quarter valued at approximately $290,000. Finally, Kestra Advisory Services LLC raised its position in ALPS Medical Breakthroughs ETF by 7.9% in the third quarter. Kestra Advisory Services LLC now owns 13,439 shares of the company's stock valued at $405,000 after purchasing an additional 985 shares during the period.
其他幾家機構投資者最近也改變了他們在SBIO的頭寸。CapTrust Financial Advisors在第一季度將其在阿爾卑斯山醫療突破ETF的股票頭寸提高了903.6%。CapTrust Financial Advisors在此期間又購買了1,500股，現在擁有1,666股該公司股票，價值56,000美元。國際資產投資管理有限責任公司在第四季度購買了阿爾卑斯山醫療突破ETF的新股份，價值約為20.2萬美元。建恩街集團有限責任公司在第一季度購買了阿爾卑斯山醫療突破ETF的新股份，價值約20.8萬美元。Citadel Advisors LLC在第三季度購買了阿爾卑斯山醫療突破ETF的新股份，價值約29萬美元。最後，Kestra Consulting Services LLC在第三季度將其在阿爾卑斯山醫療突破ETF的頭寸提高了7.9%。Kestra Consulting Services LLC在此期間又購買了985股，現在擁有13,439股該公司股票，價值40.5萬美元。
ALPS Medical Breakthroughs ETF Price Performance
阿爾卑斯山醫療突破ETF價格表現
Shares of NYSEARCA SBIO opened at $29.97 on Monday. ALPS Medical Breakthroughs ETF has a 52-week low of $23.58 and a 52-week high of $35.51. The business's 50 day moving average is $28.61 and its two-hundred day moving average is $29.92.
NYSEARCA SBIO的股價週一開盤報29.97美元。阿爾卑斯醫療突破ETF的52周低點為23.58美元，52周高位為35.51美元。該業務的50日移動均線切入位為28.61美元，200日移動均線切入位為29.92美元。
About ALPS Medical Breakthroughs ETF
關於阿爾卑斯山醫療突破ETF
(Get Rating)
(獲取評級)
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.
阿爾卑斯山醫療突破ETF(SBIO)是一隻基於S-Network醫療突破指數的交易所交易基金。該基金追蹤的是一個市值加權指數，該指數由在美國上市的生物技術公司組成，這些公司目前有一種或多種藥物正在進行FDA的第二階段或第三階段臨床試驗。SBIO於2014年12月31日推出，由阿爾卑斯山管理。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on ALPS Medical Breakthroughs ETF (SBIO)
- MarketBeat Week in Review – 4/24 – 4/28
- How to Invest in the Top Grocery Stocks for This Year
- Array Technologies Brings Solar Flare To 2023 Earnings Forecast
- Best Bank Stocks to Invest in Ahead of Rising Interest Rates
- How to Invest in Farmland: 7 Simple Ways
- 免費獲取StockNews.com關於阿爾卑斯山醫療突破ETF(SBIO)的研究報告
- 市場回顧周-4/24-4/28
- 如何投資今年最受歡迎的食品雜貨股
- 陣列技術將太陽耀斑帶到2023年收益預測
- 利率上升前最適合投資的銀行股
- 如何投資農田：7個簡單的方法
Want to see what other hedge funds are holding SBIO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO – Get Rating).
想看看其他對沖基金持有SBIO的情況嗎？訪問HoldingsChannel.com獲取阿爾卑斯山醫療突破ETF(NYSEARCA：SBIO-GET Rating)的最新13F申報和內幕交易資訊。
Receive News & Ratings for ALPS Medical Breakthroughs ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and related companies with MarketBeat.com's FREE daily email newsletter.
獲得阿爾卑斯山醫療突破ETF日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊，接收最新新聞和分析師對阿爾卑斯山醫療突破ETF及相關公司評級的每日摘要。
譯文內容由第三人軟體翻譯。